Clinical Trial

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

Study acronym: EXERT-BCHC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the impact of four standard of care, monitored group exercise regimens (resistance training) on conditioning and hypertrophy in women previously treated for breast cancer. The study will compare two conditioning regimens (6-12-25 and 8x8) and two hypertrophy regimens (5/5/5 cluster sets and double training) to assess changes in VO2 max, muscle mass, and fat mass.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-14.
Trial Details
NCT Number NCT07023887
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions Cancer, Breast Cancer
Enrollment 15 participants
Start Date 2025-05-21
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-04